GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Macter International Ltd (KAR:MACTER) » Definitions » Debt-to-Equity

Macter International (KAR:MACTER) Debt-to-Equity : 0.00 (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Macter International Debt-to-Equity?

Macter International's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₨0.00 Mil. Macter International's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₨0.00 Mil. Macter International's Total Stockholders Equity for the quarter that ended in . 20 was ₨0.00 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Macter International's Debt-to-Equity or its related term are showing as below:

KAR:MACTER's Debt-to-Equity is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.27
* Ranked among companies with meaningful Debt-to-Equity only.

Macter International Debt-to-Equity Historical Data

The historical data trend for Macter International's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Macter International Debt-to-Equity Chart

Macter International Annual Data
Trend
Debt-to-Equity

Macter International Semi-Annual Data
Debt-to-Equity

Competitive Comparison of Macter International's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Macter International's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Macter International's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Macter International's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Macter International's Debt-to-Equity falls into.


;
;

Macter International Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Macter International's Debt to Equity Ratio for the fiscal year that ended in . 20 is calculated as

Macter International's Debt to Equity Ratio for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Macter International  (KAR:MACTER) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Macter International Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Macter International's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Macter International Business Description

Traded in Other Exchanges
N/A
Address
F-216, SITE, Karachi, SD, PAK, 75700
Macter International Ltd is engaged in the manufacturing and marketing of pharmaceutical products and formulations for healthcare companies in Pakistan. It is covering almost all therapeutic categories including Antibiotics, Anti-allergy, cardiovascular, Anti-viral, and many more.

Macter International Headlines

No Headlines